These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35921345)

  • 1. Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network.
    Sun X; Wang B; Zhang J; Li M
    IEEE J Biomed Health Inform; 2022 Nov; 26(11):5757-5765. PubMed ID: 35921345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCNGAT: Drug-disease association prediction based on graph convolution neural network and graph attention network.
    Yang R; Fu Y; Zhang Q; Zhang L
    Artif Intell Med; 2024 Apr; 150():102805. PubMed ID: 38553169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graph Convolutional Autoencoder and Fully-Connected Autoencoder with Attention Mechanism Based Method for Predicting Drug-Disease Associations.
    Xuan P; Gao L; Sheng N; Zhang T; Nakaguchi T
    IEEE J Biomed Health Inform; 2021 May; 25(5):1793-1804. PubMed ID: 33216722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repositioning based on the heterogeneous information fusion graph convolutional network.
    Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A weighted bilinear neural collaborative filtering approach for drug repositioning.
    Meng Y; Lu C; Jin M; Xu J; Zeng X; Yang J
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-target Affinity Prediction by Molecule Secondary Structure Representation Network.
    Tang Y; Li Y; Li P; Liu ZP
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38409701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DTiGNN: Learning drug-target embedding from a heterogeneous biological network based on a two-level attention-based graph neural network.
    Muniyappan S; Rayan AXA; Varrieth GT
    Math Biosci Eng; 2023 Mar; 20(5):9530-9571. PubMed ID: 37161255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locality preserving dense graph convolutional networks with graph context-aware node representations.
    Liu W; Gong M; Tang Z; Qin AK; Sheng K; Xu M
    Neural Netw; 2021 Nov; 143():108-120. PubMed ID: 34116289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repositioning based on heterogeneous networks and variational graph autoencoders.
    Lei S; Lei X; Liu L
    Front Pharmacol; 2022; 13():1056605. PubMed ID: 36618933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug-disease associations based on reinforcement symmetric metric learning and graph convolution network.
    Luo H; Zhu C; Wang J; Zhang G; Luo J; Yan C
    Front Pharmacol; 2024; 15():1337764. PubMed ID: 38384286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GVDTI: graph convolutional and variational autoencoders with attribute-level attention for drug-protein interaction prediction.
    Xuan P; Fan M; Cui H; Zhang T; Nakaguchi T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34718408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of circRNA-Disease Associations Based on the Combination of Multi-Head Graph Attention Network and Graph Convolutional Network.
    Cao R; He C; Wei P; Su Y; Xia J; Zheng C
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchical Negative Sampling Based Graph Contrastive Learning Approach for Drug-Disease Association Prediction.
    Wang Y; Song J; Dai Q; Duan X
    IEEE J Biomed Health Inform; 2024 May; 28(5):3146-3157. PubMed ID: 38294927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning global dependencies and multi-semantics within heterogeneous graph for predicting disease-related lncRNAs.
    Xuan P; Wang S; Cui H; Zhao Y; Zhang T; Wu P
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 36088549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDPI: adaptively learning importance of multi-scale topologies and multi-modality similarities for drug-protein interaction prediction.
    Hu K; Cui H; Zhang T; Sun C; Xuan P
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35108362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusing graph transformer with multi-aggregate GCN for enhanced drug-disease associations prediction.
    He S; Yun L; Yi H
    BMC Bioinformatics; 2024 Feb; 25(1):79. PubMed ID: 38378479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HINGRL: predicting drug-disease associations with graph representation learning on heterogeneous information networks.
    Zhao BW; Hu L; You ZH; Wang L; Su XR
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EmbedDTI: Enhancing the Molecular Representations via Sequence Embedding and Graph Convolutional Network for the Prediction of Drug-Target Interaction.
    Jin Y; Lu J; Shi R; Yang Y
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning.
    Du X; Sun X; Li M
    J Chem Inf Model; 2024 Jun; 64(12):4928-4937. PubMed ID: 38837744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-Path Semantic and Global-Local Representation Learning Enhanced Graph Convolutional Model for Disease-Related miRNA Prediction.
    Xuan P; Wang X; Cui H; Meng X; Nakaguchi T; Zhang T
    IEEE J Biomed Health Inform; 2024 Jul; 28(7):4306-4316. PubMed ID: 38709611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.